Error: Could not add to watchlist. X

Seattle Genetics Inc

+ Watchlist
SGEN:US
NASDAQ GS
41.24
USD
0.98
2.43%
As of 20:10:00 ET on 08/27/2015.
Open
40.89
Day Range
40.30 - 41.87
Volume
715,750
Previous Close
40.26
52Wk Range
30.05 - 52.33
1 Yr Return
-5.35%
Open
40.89
Day Range
40.30 - 41.87
Volume
715,750
Previous Close
40.26
52Wk Range
30.05 - 52.33
1 Yr Return
-5.35%
YTD Return
28.35%
Current P/E Ratio (TTM)
-
Earnings per Share (USD) (TTM)
-0.90
Market Cap (b USD)
5.169
Shares Outstanding (m)
125.340
Price/Sales (TTM)
16.56
Dividend Indicated Gross Yield
-
Sector
Health Care
Industry
Biotech & Pharma
Sub-Industry
Biotech

Related Videos

There are currently no related videos for this ticker. Please check back later.
Profile
Seattle Genetics, Inc. discovers and develops monoclonal antibody-based drugs to treat cancer and related diseases. The Company's technologies increase the potency and efficacy of monoclonal antibodies with specificity for cancer.
ADDRESS
21823 30th Drive SE
Bothell, WA 98021
United States
PHONE
1-425-527-4000
  • Clay B Siegall
    Chairman/Pres/CEO/Co-Founder
  • Todd E Simpson
    Chief Financial Officer
  • Eric L Dobmeier
    COO/Secretary
  • Jean I Liu
    Exec VP:Legal Affairs/Gen Counsel/Secy
  • Jonathan Drachman
    Exec VP:Research & Dev
Show More